Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Central Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 3, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,126	2,168	1,486	1,569	1,581	1,593
Market Cap Growth	10.59%	45.97%	-5.34%	-0.76%	-0.75%	5.56%
Enterprise Value	1,393	2,454	1,752	1,818	1,803	1,818
Last Close Price	9.40	18.10	12.40	13.10	13.20	13.30
PS Ratio	160.44	73.26	50.65	60.37	10.67	11.37
PB Ratio	1.33	2.57	2.22	2.20	2.02	2.02
P/TBV Ratio	1.33	2.57	2.22	2.20	2.02	2.02
P/FCF Ratio	-	731.27	-	-	-	-
P/OCF Ratio	458.35	731.27	-	-	880.40	-
EV/Sales Ratio	198.51	82.90	59.75	69.92	12.17	12.97
EV/EBITDA Ratio	-	-	-	-	45.42	-
EV/EBIT Ratio	-	-	-	-	264.59	-
EV/FCF Ratio	-	827.53	-	-	-	-
Debt / Equity Ratio	0.32	0.32	0.40	0.38	0.32	0.29
Debt / EBITDA Ratio	-	-	-	-	6.33	-
Debt / FCF Ratio	109.27	90.64	-	-	-	-
Asset Turnover	0.01	0.02	0.02	0.02	0.11	0.07
Inventory Turnover	1.25	2.55	1.90	1.26	2.06	1.95
Quick Ratio	0.22	0.23	0.25	0.25	0.26	0.20
Current Ratio	1.15	1.14	1.18	1.25	1.37	1.31
Return on Equity (ROE)	-4.82%	-5.60%	-6.35%	-9.12%	-1.08%	-86.06%
Return on Assets (ROA)	-1.78%	-1.74%	-2.32%	-2.49%	0.31%	-35.91%
Return on Capital (ROIC)	-2.34%	-2.30%	-3.12%	-3.31%	0.42%	-45.76%
Return on Capital Employed (ROCE)	-3.50%	-3.40%	-5.10%	-5.40%	0.60%	-104.40%
Earnings Yield	-3.23%	-1.96%	-2.96%	-4.35%	-0.54%	-69.48%
FCF Yield	-	0.14%	-0.02%	-0.07%	-0.30%	-0.03%
Buyback Yield / Dilution	1.29%	-	-	-	-	-
Total Shareholder Return	1.29%	-	-	-	-	-

Updated Dec 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.